Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Recurrence of severe symptomatic late-onset neutropenia on ocrelizumabMult. Scler. 2023 Oct 27;[EPub Ahead of Print], Y Beigneux, C Louapre, K Bihan, T Roux, R de Paz, C Lubetzki, E Maillart
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.